PREVIEW #ESMO26 — pre-conference KOL intelligence for the ESMO Congress 2026 in Madrid, Oct 23–27 See the Preview →
KOL PULSE AI
#IMS26 · CONFERENCE INTELLIGENCE · Influencer Networks

IMS 2026 Recap:
Who Drove the Conversation?

Conference-week snapshot, data through October 1, 2026 · Sep 23–26, 2026 · Glasgow, UK · 852 curated posts · interactive retweet/mention graph. Part of the KOL Pulse IMS26 Conference Intelligence series.

567
Accounts Analyzed
354
Classified Accounts
96
Verified US Physicians
28
Countries
See the live IMS 2026 conference coverage — themes, top voices & trial buzz →
›
How to Use This Report
A working tool for following up after Glasgow, not a leaderboard for its own sake

Follow-up: click any KOL card to isolate their retweet graph and see who moves their content; click a state on the map to pull the verified physicians there with institution and trial interests — the people to follow up with after Glasgow, organized the way you plan territory. The trial dropdown filters the graph to the voices already discussing a specific readout.

Reading the network: node size is reach, edges are actual retweets and mentions from the conference window — not follower counts. Clusters show which communities (US academic, EU cooperative groups, patient organizations, media) are organized around which topics.

Amplifiers vs authors: the leaderboard ranks who writes; the amplifier board below ranks who spreads. If you want a message carried into the post-IMS26 conversation, the amplifier list is the distribution map.

Data through October 1, 2026. Engagement (retweet/quote) enrichment is ongoing for this corpus — the network below reflects whatever retweet data has landed so far and will fill in as enrichment continues.

1
Top KOLs by Impression
Click any KOL to filter the network below to just their retweeter graph
#1
Vincent Rajkumar
@vincentrk
104.0K imp · 17 tweets
Us Kol
#2
Rahul Banerjee, MD, FACP
@rahulbanerjeemd
75.5K imp · 45 tweets
Us Kol
#3
Samer Al Hadidi, MD,MS,F
@hadidisamer
37.5K imp · 55 tweets
Us Kol
#4
Mehak Trehan
@mehak_trehan
17.5K imp · 31 tweets
Kol
#5
Mohamad Mohty
@mohty_ebmt
16.4K imp · 9 tweets
Kol
#6
Hamza Hashmi
@hhashmi87
14.8K imp · 38 tweets
Us Kol
#7
Hira Mian
@hirasmian
11.0K imp · 10 tweets
Kol
#8
Joshua Richter, MD, FACP
@joshuarichtermd
10.9K imp · 13 tweets
Us Kol
#9
Al-Ola A Abdallah MD (US
@abdallah81md
7.9K imp · 7 tweets
Us Kol
#10
Henry C Fung
@henrychihangfu1
7.3K imp · 7 tweets
Us Kol
★
Top Amplifiers — Recognition Board
The accounts spreading the conference conversation: most corpus posts retweeted or quoted
#1
Rahul Banerjee, MD, FACP
@rahulbanerjeemd
140 posts amplified
US Physician
#2
SomeoneSomewhere
@someone68423357
89 posts amplified
Patient Advocacy
#3
Chidambara .ML.
@chidambara09
72 posts amplified
Industry
#4
Beth Faiman PhD
@bethfaiman
59 posts amplified
Patient Advocacy
#5
P O O M ( 품 )
@giroh
46 posts amplified
Community
#6
Simon C
@scserendipity1
39 posts amplified
Int'l Physician
#7
Gurbakhash Kaur
@gkaurmd
33 posts amplified
US Physician
#8
Mike Thompson, MD, PhD, FASCO
@mtmdphd
30 posts amplified
US Physician
#9
Santhosh Ambika
@renohemonc
27 posts amplified
US Physician
#10
Yi Lin
@yilinmdphd
26 posts amplified
US Physician
#11
Murali Janakiram
@janakirammurali
25 posts amplified
US Physician
#12
Victor H Jimenez-Zepeda
@vhugo8762
20 posts amplified
Patient Advocacy
2
Category Breakdown
Voice composition across the 567 accounts identified
US Physicians
96
Intl Physicians
87
General Public
33
Media (medical + finance)
28
Bot/Inactive
26
Patient Organizations
20
Researchers
17
Pharma Companies
14
Institutions
11
Pharma Industry
9
Conference Organizations
3
Nurse/APP
2
Investors
2
Larvol_Fans
2
Pharma Individual
1
Finance
1
Tech/Health
1
Medical Students / Trainees
1
3
Verified US Physicians by State
94 of 96 verified US physicians mapped across 28 states
Verified US physicians 1 2–3 4–5 6+ Click any state to see physicians
4
Non-US Physicians by Country
79 verified non-US physicians across 27 countries (an additional 8 physician-like accounts have no country evidence)
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
5
Influencer Network
Force-directed retweet graph — 530 nodes, 1129 edges. Drag, zoom, click nodes for details.
View:
US Influence:
Other:
Top 10 KOL networks:
US Physicians KOLs Media Institutions Pharma Retweeters
6
Top KOL Voices
Highest-impact physician/researcher voices — institutional and media accounts excluded
AccountCategoryInstitutionLocationTopics & TrialsTweetsImpressions
Vincent Rajkumar
US KOLMayo Clinic, RochesterMN
BCMA ADCs (Belantamab)Bispecific T-Cell EngagersCAR-T TherapyCERVINOPERSEUS
17104.0K
Rahul Banerjee, MD, FACP
US KOLFred Hutchinson Cancer Center / UniversiWA
Bispecific T-Cell EngagersCAR-T TherapyCELMoDs & IMiDsAnito-cel-Phase1CARTITUDE-2 Cohort A
4575.5K
Samer Al Hadidi, MD,MS,FACP
US KOLUT Southwestern Medical CenterTX
Bispecific T-Cell EngagersCAR-T TherapyCELMoDs & IMiDsAnito-cel-Phase1CAMMA 1
5537.5K
Mehak Trehan
Intl KOLFortis Memorial Research Institute (FMRIIndia
BCMA ADCs (Belantamab)Bispecific T-Cell EngagersCAR-T TherapyProMMiseTRIlogy-1
3117.5K
Mohamad Mohty
Intl KOLHôpital Saint-Antoine, Sorbonne UniversiFrance
Bispecific T-Cell EngagersCAR-T TherapyCELMoDs & IMiDsCERVINODURGA-6
916.4K
Hamza Hashmi
US KOLMedical University of South Carolina (MUSC
BCMA ADCs (Belantamab)Bispecific T-Cell EngagersCAR-T TherapyCAMMA 1CARTITUDE-2 Cohort A
3814.8K
Hira Mian
Intl KOLMcMaster University / Juravinski Cancer Canada
Bispecific T-Cell EngagersCAR-T TherapyMRD & Response DepthCERVINO
1011.0K
Joshua Richter, MD, FACP
US KOLTisch Cancer Institute, Mount SinaiNY
Bispecific T-Cell EngagersCAR-T Therapy
1310.9K
Al-Ola A Abdallah MD (USMIRC)
US KOLUniversity of Kansas Medical CenterKS
Bispecific T-Cell EngagersCAR-T TherapyCELMoDs & IMiDsAnito-cel-Phase1CERVINO
77.9K
Henry C Fung
US KOLFox Chase Cancer CenterPA
Bispecific T-Cell EngagersCAR-T TherapyCELMoDs & IMiDsCEPHEUSCERVINO
77.3K
Saurabh Zanwar
US KOLMayo Clinic, RochesterMN
Bispecific T-Cell EngagersCAR-T TherapyAnito-cel-Phase1CARTITUDE-4
77.0K
Ankit kansagra
US KOLTampa General Hospital Cancer InstituteFL
Bispecific T-Cell EngagersFrontline NDMM & QuadrupletsMRD & Response DepthCERVINOEXCALIBER-RRMM
105.8K
Rafael Fonseca MD
US KOLMayo Clinic, ArizonaAZ
CAR-T TherapyTRIlogy-1
35.7K
Murali Janakiram
US KOLCity of HopeCA
Bispecific T-Cell EngagersCAR-T TherapyCELMoDs & IMiDs
64.9K
Yi Lin
US KOLMayo Clinic Comprehensive Cancer CenterMN
CAR-T TherapyDART
74.2K
Eddie Cliff
US KOLPeter MacCallum Cancer Centre / Royal MeMA
—
14.0K
Breno Moreno de Gusmão
Intl KOLBP - A Beneficência Portuguesa de São PaBrazil
BCMA ADCs (Belantamab)Bispecific T-Cell EngagersCAR-T TherapyCAMMA 1CERVINO
183.4K
Mansi Shah
US KOLRutgers Cancer Institute of New Jersey (NJ
—
22.7K
Urvi Shah
US KOLMemorial Sloan Kettering Cancer CenterNY
CAR-T Therapy
12.4K
Rakesh Popat
Intl KOLUCLH / UCLUK
Bispecific T-Cell Engagers
22.4K
Gurbakhash Kaur
US KOLMount Sinai Health System, NYNY
BCMA ADCs (Belantamab)CAR-T TherapyFrontline NDMM & Quadruplets
42.3K
Bhausaheb Bagal
Intl KOLTata Memorial Center, MumbaiIndia
—
42.3K
Meral Beksac
Intl KOLLiv Hospital / Istinye UniversityTurkey
Transplant & MaintenanceCARTITUDE-4DURGA-6
62.3K
Pablo Tenorio Feixas
Intl KOLKing's College Hospital NHS Foundation TUK
Bispecific T-Cell EngagersCAR-T TherapyDisease Monitoring & Mass SpecCERVINO
162.0K
Eric Smith
US KOLDana-Farber Cancer InstituteMA
Bispecific T-Cell Engagers
11.7K
Thanos Dimopoulos
Intl KOLNational and Kapodistrian University of Greece
EXCALIBER-RRMM
21.6K
Raj Chakraborty
US KOLColumbia University / Herbert Irving CCCNY
Bispecific T-Cell Engagers
11.4K
Dr. Minoo Battiwalla
US KOLSarah Cannon / TriStar Centennial, NashvTN
CAR-T Therapy
41.2K
Shaji Kumar
US KOLMayo Clinic RochesterMN
—
11.1K
Simon Stern
Intl KOLEpsom and St Helier University HospitalsUK
Transplant & Maintenance
2875
Are you on this map?

Are you a KOL?

Want to learn more about your network — your reach, engagement, and influence across IMS 2026 and the wider oncology conversation? Sign up for a free custom KOL report.

?
Questions This Network Answers
The data on this page, summarized — and how to actually use it

What does this network show?

A force-directed map of who actually moves the IMS 2026 conversation: 530 accounts connected by 1129 real retweet, quote, and mention relationships from the conference window — not follower counts. 176 of the mapped accounts are verified physicians, spanning 29 countries. The leaderboard ranks the authors; the amplifier board ranks the 501 accounts doing the spreading — led by Rahul Banerjee, MD, FACP with 140 posts amplified.

Who does a KOL influence — and who amplifies their content?

Take Vincent Rajkumar, the meeting’s most prolific voice: amplified by 211 distinct accounts, 371 times. The makeup of that amplifier network: 92 physicians, 9 patient advocates, 2 media accounts — a clinical audience, not bot inflation. The US physicians who amplify this content most: Rahul Banerjee, MD, FACP (9), Gurbakhash Kaur (6), Mike Thompson, MD, PhD, FASCO (6), Surbhi Sidana, MD (5); internationally, Tontarn Chutima (8), Adrián Alegre, MD, PhD (7). That is the practical answer to “who do they influence?”: the named, verified carriers who move a KOL’s content into each community. Click any KOL card above to run the same analysis visually on their retweeter graph.

How can medical affairs and pharma teams use this network?

Engagement sequencing: the leaderboard tells you who writes, the amplifier board tells you who spreads, and the edges tell you which specific accounts connect them. If a readout needs to reach US academic myeloma during IMS26 week, the amplifier list is the distribution map — and influence-mapping practice guides note that knowing the carriers prevents redundant outreach to already-saturated voices. Pair with the attendee network for rosters by state, institution, and trial interest.

Why does influence mapping matter in oncology?

Congress weeks are when oncology opinion forms: standards shift with each readout and physicians learn about the data from each other in real time — surveys report over 70% of HCPs use digital channels weekly, and in a LiveWorld–Sermo survey, 41% of US physicians said social media influences prescribing. Publication records show who built the evidence; this graph shows who carries it — measured in actual retweet relationships, before the meeting begins.

How can I use this network with my favorite AI tool?

Paste this URL into ChatGPT, Gemini, Claude, or Perplexity and ask the questions this graph answers: “Who are the top amplifiers of IMS 2026 content and what kinds of accounts are they?”, “What is the makeup of Vincent Rajkumar’s amplifier network?”, “Which US physicians amplify the leading international voices?” For who-is-attending questions (states, institutions, trial interests), use the attendee network. Cite kolpulse.com when you share the answers.

More IMS 2026 Myeloma Coverage
CERVINO Trial Profile
Etentamig ORR/PFS data, KOL voices & FDA status
IMS 2026 Conference Hub
Top KOL voices, trial buzz & conference themes
Virtual Attendee Network
Who tweeted at IMS26, by category & region
IMS 2026 Slide Library
Every data slide shared at IMS26, organized by trial